Concordance of the toxicity of pharmaceuticals in humans and in animals

H Olson, G Betton, D Robinson, K Thomas… - Regulatory toxicology …, 2000 - Elsevier
This report summarizes the results of a multinational pharmaceutical company survey and
the outcome of an International Life Sciences Institute (ILSI) Workshop (April 1999), which …

Evolution of science-based uncertainty factors in noncancer risk assessment

ML Dourson, SP Felter, D Robinson - Regulatory Toxicology and …, 1996 - Elsevier
The science behind the use of uncertainty factors has progressed considerably. Increased
knowledge of inter-and intraspecies sensitivity, mechanisms of action, and detailed …

Unrealistic expectations and problem-solving ability in maltreating and comparison mothers.

ST Azar, DR Robinson, E Hekimian… - Journal of consulting …, 1984 - psycnet.apa.org
Administered a child development questionnaire, a parent opinion questionnaire, and a
parent problem-solving instrument to 10 abusing mothers, 10 neglectful mothers, and 10 …

Chloroform mode of action: implications for cancer risk assessment

RJ Golden, SE Holm, DE Robinson… - Regulatory toxicology …, 1997 - Elsevier
Risk assessment methodology, particularly pertaining to potential human carcinogenic risks
from exposures to environmental chemicals, is undergoing intense scrutiny from scientists …

Do peroxisome proliferating compounds pose a hepatocarcinogenic hazard to humans?

RC Cattley, J DeLuca, C Elcombe… - Regulatory Toxicology …, 1998 - Elsevier
The purpose of the workshop “Do Peroxisome Proliferating Compounds Pose a
Hepatocarcinogenic Hazard to Humans?” was to provide a review of the current state of the …

[HTML][HTML] The absorption of oral micronized progesterone: the effect of food, dose proportionality, and comparison with intramuscular progesterone

JA Simon, DE Robinson, MC Andrews… - Fertility and sterility, 1993 - Elsevier
Objectives To examine the effects of food ingestion and administered dose on the
absorption of oral micronized P (Utrogestan; Besins-Iscovesco, Paris, France) and to …

The predictivity of the toxicity of pharmaceuticals in humans from animal data—an interim assessment

H Olson, G Betton, J Stritar, D Robinson - Toxicology letters, 1998 - Elsevier
This project was undertaken by the International Life Sciences Institute's Health and
Environmental Sciences Institute (ILSI-HESI) to develop an improved understanding of the …

Background and framework for ILSI's collaborative evaluation program on alternative models for carcinogenicity assessment

DE Robinson, JS Macdonald - Toxicologic pathology, 2001 - journals.sagepub.com
The willingness of the agencies involved in the regulation of pharmaceuticals to accept data
from newly proposed models for carcinogenicity testing (eg, transgenic animals, neonatal …

Use of transgenic animals for carcinogenicity testing: considerations and implications for risk assessment

D Gulezian, D Jacobson-Kram… - Toxicologic …, 2000 - journals.sagepub.com
Advances in genetic engineering have created opportunities for improved understanding of
the molecular basis of carcinogenesis. Through selective introduction, activation, and …

A physiologically based pharmacokinetic model for nicotine and cotinine in man

DE Robinson, NJ Balter, SL Schwartz - Journal of pharmacokinetics and …, 1992 - Springer
Physiologically based pharmacokinetic (PBPK) models have been developed describing the
disposition kinetics of nicotine and its major metabolite, cotinine, in man. Separate 9 …